"Piedmont Physicians Pulmonary and Sleep Medicine specializes in the treatment and management of lung diseases, sleep disorders and allergies."

During the past decade, Piedmont Healthcare Pulmonary and Critical Care Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Piedmont Healthcare Pulmonary and Critical Care Research" #1 sponsor was "United Therapeutics" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored, "Kadmon Corporation, LLC" with 1 trials sponsored and "Pliant Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Healthcare Pulmonary and Critical Care Research" #1 collaborator was "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Healthcare Pulmonary and Critical Care Research" are "Idiopathic Pulmonary Fibrosis" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials) and "Familial Primary Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "Piedmont Healthcare Pulmonary and Critical Care Research" in a lesser frequency.

Most popular intervention types in "Piedmont Healthcare Pulmonary and Critical Care Research" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ralinepag" (2 trials), "BSC" (1 trials), "Belumosudil" (1 trials) and "Inhaled Nitric Oxide 75 mcg/kg IBW/hr" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Healthcare Pulmonary and Critical Care Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Healthcare Pulmonary and Critical Care Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Piedmont Healthcare Pulmonary and Critical Care Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Healthcare Pulmonary and Critical Care Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".